Fox Business - The Power to Prosper
Search Site

Quest Diagnostics

Are Quest Diagnostics shares a healthy addition to your portfolio?

FBN’s Charles Payne, A&G Capital CIO Hilary Kramer and Penn Financial Group founder Matt McCall on the outlook for Quest Diagnostics .

Read More

  1. Tough times for consumer stocks

    The Long Term GARP portfolio performed poorly in January and fell 5.0%, compared with a 2.8% decline in the S&P 500 Index (SPX) .So far this year, the biggest stock ...

  2. Quest Buys Solstas Lab for $570M

    Quest Diagnostics (NYSE:DGX) agreed on Wednesday to pay a private equity firm $570 million for Solstas Lab Partners Group, as the testing provider continues to expan...

  3. Get ready for Fed tapering in 2014

    The Covestor Long Term GARP portfolio gained 4.3% in November, better than the 3.8% advance of the S&P 500. December is typically a good month for the market, althou...

  4. Balancing offense and defense in your investing

    Like sports dynasties, investment manager Yale Bock thinks strong portfolios are constructed with the right mix of offense and defense."I'm trying to put together po...

  5. Drugs in the Workforce: A Startling Reality

    Drug use among American workers has dropped dramatically over the past 25 years, but certain drugs—particularly prescription medications--continue to be abused in th...

  6. Challenging September for the Long Term GARP Portfolio

    The Covestor Long Term GARP portfolio performed well in September in an eventful month on the macroeconomic front. The second half of the month was influenced negati...

  7. Exclusive: Activist investor sends Alere letter calling for unit sales

    An activist investor who has been campaigning for change at Alere Inc sent the company a letter on Monday calling for the health diagnostics and services company to ...

  8. The Long Term GARP portfolio delivers in April

    By Yale BockThe Long Term GARP investment portfolio rose 1.2% (net of fees) in the month of April 2013, which was better than the S&P 500 Index performance of 1.8%. ...

  9. Quest Diagnostics Acquires Concentra's Lab Business

    Quest Diagnostics Inc. (DGX) acquired the toxicology and clinical laboratory business of Concentra, a medical center operator owned by Humana Inc. (HUM), as the diag...

  10. Health-Care Companies Report Slowdown in Patient Visits

    The spike late last year in doctor and hospital visits apparently lasted as long as the flu.After years of decelerating health-care usage--linked to economic problem...

  11. Analysis: Ahead of reform, medical care slowdown hits companies

    As the clock ticks down to the start of a U.S. healthcare overhaul, companies from device makers to hospital chains have been surprised to see Americans make even fe...

  12. Quest Diagnostics Hikes Dividend, Ups Cost Cutting

    Quest Diagnostics said Friday it's increasing its quarterly dividend by 76% to 30 cents a share. It'll be payable on Jan. 28 to shareholders of record on Jan. 11. Th...

  1. Quest Diagnostics has huge 4Q, 2015 projections

    Quest Diagnostics CEO Steve Rusckowski on the company’s big earnings report and outlook for 2015.

  2. Quest Diagnostics CEO on impact of ObamaCare, cancer treatments

    Quest Diagnostics CEO Steve Rusckowski discusses the growth of the company, its recent acquisitions, the impact of ObamaCare on the company and fighting cancer.

  3. Former HP CEO talks taxes

    Former Hewlett-Packard CEO Carly Fiorina gives her thoughts on President Obama’s action on Syria tax inversions and fighting the spread of Ebola.

  4. Theranos CEO on company’s blood testing system

    Theranos CEO Elizabeth Holmes on her company and the landscape of U.S. diagnostic-lab industry.

  5. Market correction coming?

    S&P Capital IQ chief equity strategist Sam Stovall and Wells Fargo Securities senior equity strategist Gina Martin Adams on whether 2014 will be a year of consolidation.

  6. Investing in trends that don’t have an ETF

    Motif Investing CEO Hardeep Walia on how to invest in a basket of stocks based on certain trends.

  7. Get ready for a bumpy ride in the markets

    The Long Term GARP portfolio rose 6.7% in February, better than the 5% gain of the S&P 500 Index (SPX) .As earnings reports have rolled in over the last six weeks, w...

‹ Prev12Next ›
Freebase CC-BY
Source: Quest Diagnostics on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL